These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32620010)

  • 1. Pregnancy Per- and Polyfluoroalkyl Substance Concentrations and Postpartum Health in Project Viva: A Prospective Cohort.
    Mitro SD; Sagiv SK; Fleisch AF; Jaacks LM; Williams PL; Rifas-Shiman SL; Calafat AM; Hivert MF; Oken E; James-Todd TM
    J Clin Endocrinol Metab; 2020 Sep; 105(9):e3415-26. PubMed ID: 32620010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Per- and Polyfluoroalkyl Substances and Hormone Levels During the Menopausal Transition.
    Harlow SD; Hood MM; Ding N; Mukherjee B; Calafat AM; Randolph JF; Gold EB; Park SK
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4427-e4437. PubMed ID: 34181018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States).
    Cluett R; Seshasayee SM; Rokoff LB; Rifas-Shiman SL; Ye X; Calafat AM; Gold DR; Coull B; Gordon CM; Rosen CJ; Oken E; Sagiv SK; Fleisch AF
    Environ Health Perspect; 2019 Aug; 127(8):87006. PubMed ID: 31433236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per- and Polyfluoroalkyl Substance Exposure, Gestational Weight Gain, and Postpartum Weight Changes in Project Viva.
    Mitro SD; Sagiv SK; Rifas-Shiman SL; Calafat AM; Fleisch AF; Jaacks LM; Williams PL; Oken E; James-Todd TM
    Obesity (Silver Spring); 2020 Oct; 28(10):1984-1992. PubMed ID: 32959518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women.
    Ding N; Karvonen-Gutierrez CA; Herman WH; Calafat AM; Mukherjee B; Park SK
    Int J Hyg Environ Health; 2021 Jun; 235():113777. PubMed ID: 34090141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentrations of per- and polyfluoroalkyl substances in pregnancy and breastfeeding duration in Project Viva.
    Rokoff LB; Wallenborn JT; Harris MH; Rifas-Shiman SL; Criswell R; Romano ME; Young JG; Calafat AM; Oken E; Sagiv SK; Fleisch AF
    Sci Total Environ; 2023 Sep; 891():164724. PubMed ID: 37290653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations.
    Sagiv SK; Rifas-Shiman SL; Webster TF; Mora AM; Harris MH; Calafat AM; Ye X; Gillman MW; Oken E
    Environ Sci Technol; 2015 Oct; 49(19):11849-58. PubMed ID: 26333069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
    Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
    Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial.
    Cardenas A; Gold DR; Hauser R; Kleinman KP; Hivert MF; Calafat AM; Ye X; Webster TF; Horton ES; Oken E
    Environ Health Perspect; 2017 Oct; 125(10):107001. PubMed ID: 28974480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Concentrations of Per- and Polyfluoroalkyl Substances and Body Composition From Mid-Childhood to Early Adolescence.
    Janis JA; Rifas-Shiman SL; Seshasayee SM; Sagiv S; Calafat AM; Gold DR; Coull BA; Rosen CJ; Oken E; Fleisch AF
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3760-e3770. PubMed ID: 33740056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.
    Lin PD; Cardenas A; Hauser R; Gold DR; Kleinman KP; Hivert MF; Calafat AM; Webster TF; Horton ES; Oken E
    Environ Int; 2020 Apr; 137():105573. PubMed ID: 32088543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal Exposure to Perfluoroalkyl Substances and Cardiometabolic Risk in Children from the Spanish INMA Birth Cohort Study.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Romaguera D; Fernández-Barrés S; Santa-Marina L; Basterretxea M; Schettgen T; Valvi D; Vioque J; Sunyer J; Vrijheid M
    Environ Health Perspect; 2017 Sep; 125(9):097018. PubMed ID: 28934720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of diet with per- and polyfluoroalkyl substances in plasma and human milk in the New Hampshire Birth Cohort Study.
    Wang Y; Gui J; Howe CG; Emond JA; Criswell RL; Gallagher LG; Huset CA; Peterson LA; Botelho JC; Calafat AM; Christensen B; Karagas MR; Romano ME
    Sci Total Environ; 2024 Jul; 933():173157. PubMed ID: 38740209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early-Life Exposure to Perfluoroalkyl Substances and Childhood Metabolic Function.
    Fleisch AF; Rifas-Shiman SL; Mora AM; Calafat AM; Ye X; Luttmann-Gibson H; Gillman MW; Oken E; Sagiv SK
    Environ Health Perspect; 2017 Mar; 125(3):481-487. PubMed ID: 27586368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones.
    Pacyga DC; Papandonatos GD; Rosas L; Whalen J; Smith S; Park JS; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
    Int J Hyg Environ Health; 2024 Jun; 259():114380. PubMed ID: 38657330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal perfluoroalkyl substances and newborn anogenital distance in a Canadian cohort.
    Arbuckle TE; MacPherson S; Foster WG; Sathyanarayana S; Fisher M; Monnier P; Lanphear B; Muckle G; Fraser WD
    Reprod Toxicol; 2020 Jun; 94():31-39. PubMed ID: 32283250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to per- and polyfluoroalkyl substances and maternal and neonatal thyroid function in the Project Viva Cohort: A mixtures approach.
    Preston EV; Webster TF; Claus Henn B; McClean MD; Gennings C; Oken E; Rifas-Shiman SL; Pearce EN; Calafat AM; Fleisch AF; Sagiv SK
    Environ Int; 2020 Jun; 139():105728. PubMed ID: 32311629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isomers of per- and polyfluoroalkyl substances and uric acid in adults: Isomers of C8 Health Project in China.
    Zeng XW; Lodge CJ; Dharmage SC; Bloom MS; Yu Y; Yang M; Chu C; Li QQ; Hu LW; Liu KK; Yang BY; Dong GH
    Environ Int; 2019 Dec; 133(Pt A):105160. PubMed ID: 31518937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Plasma per- and Polyfluoroalkyl Substance Concentrations in Early Pregnancy and Maternal and Neonatal Thyroid Function in a Prospective Birth Cohort: Project Viva (USA).
    Preston EV; Webster TF; Oken E; Claus Henn B; McClean MD; Rifas-Shiman SL; Pearce EN; Braverman LE; Calafat AM; Ye X; Sagiv SK
    Environ Health Perspect; 2018 Feb; 126(2):027013. PubMed ID: 29488882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.